偏头痛（Migraine Headache）是一种常见的头痛类型，其诊断代码在ICD-9中为300，而在ICD-10中则为G109。这种头痛通常表现为中到重度的搏动性疼痛，常常出现在头部的一侧，并可能伴有恶心、呕吐、畏光和畏声等症状。偏头痛的发作可能会持续数小时至数天，且常常具有周期性。对于偏头痛患者来说，了解其全面的信息，...
ICD-10 (online.) Genf: WHO. URL:hppt://www.dmdi.de/dynamic/de/klassi/diagnosen/icd10/htmlamtl2006/fr- icd.htm (Zugriff am 09.05.2010).Weintraub JR. Treatment of acute migraine attacks. J Am Osteopath Assoc. 2000; 100 (9 Suppl):S1–S7.Weintraub, J.R. (2000): Treatment of ...
ICD-10 CODE G43.109临床综合征偏头痛是一种周期性发作的单侧头痛,它可能起源于儿童时期,大部分在30岁前开始发病。其发作的频率不固定,从几天一次到几个月一次都有可能。频繁发作的偏头痛通常和镇痛药物反弹现象(analgesic rebound)有关。偏头痛患者60%~70%为女性,多伴有家族史。偏头痛患者人格特征常表现为一丝...
2.4.2. Acute treatment In terms of the acute treatment effect of e-TNS during the migraine attack, the intensity of pain was measured on a VAS scale (0-no pain to 10-maximum pain), immediately after one hour treatment session, and at two and 24 h after the beginning of the treatment...
However, the magnitude of the increases was significantly lower for the galcanezumab cohort than for the rimegepant cohort.Treatment discontinuation rate was significantly lower in the galcanezumab versus the rimegepant cohort.Springer HealthcareAdvances in TherapyGilwan Kimhttps://ror.org/01qat...
This study examined treatment patterns and healthcare resource utilization (HRU) in patients with migraine using real-world data from Alberta. Methods: This was a retrospective cohort study of patients with ≥1 ICD-9-CM/ICD-10-CA code for migraine or ≥1 prescription for a triptan from April...
More is known about the genetics and biology of migraine than any other pain disorder, leading to recent treatment advances such as those targeting the calcitonin gene-related peptide (CGRP) activation of the trigeminovascular system9,10. The largest genome-wide association studies (GWAS) meta-ana...
Acute dystonic reactions, akathisia, or drug-induced tremors are not rare in patients who are receiving treatment for migraine that includes phenothiazines or neuroleptic drugs for migraine-associated nausea or pain. Less common neuroleptic-related problems, such as drug-induced parkinsonism or ...
The present invention provides methods for the treatment or prevention of major depressive disorder with anxiety without concomitant therapy with other anti-depressant or anti-anxiety agents which comprises oral administration of an oral... R Baker,NR Curtis,JM Elliott,... - WO 被引量: 29发表: ...
for migraine pathophysiology Anika Hunfeld, Daniel Segelcke, Ingo Bäcker, Badreddine Mecheri, Kathrin Hemmer, Elisabeth Dlugosch, Michael Andriske, Frank Paris, Xinran Zhu & Hermann Lübbert Migraine animal models generally mimic the onset of attacks and acute treatment ...